-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BjWydF1LPheEeACpltVI4PZwnrLCzRFQiy5eE6sLdzvXMkB5C9gxSi02oG15z1RU FjAjP7RFZXKXd4wLRLA3Rg== 0001275287-07-001573.txt : 20070330 0001275287-07-001573.hdr.sgml : 20070330 20070330145006 ACCESSION NUMBER: 0001275287-07-001573 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070330 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070330 DATE AS OF CHANGE: 20070330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPHERIX INC CENTRAL INDEX KEY: 0000012239 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT [8700] IRS NUMBER: 520849320 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-05576 FILM NUMBER: 07731957 BUSINESS ADDRESS: STREET 1: 12051 INDIAN CREEK CT CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 3014193900 MAIL ADDRESS: STREET 1: 12051 INDIAN CREEK COURT CITY: BELTSVILLE STATE: MD ZIP: 20705 FORMER COMPANY: FORMER CONFORMED NAME: BIOSPHERICS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: BIOSPHERICS RESEARCH INC DATE OF NAME CHANGE: 19720404 8-K 1 si9480.txt FORM 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 30, 2007 SPHERIX(R) INCORPORATED ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 0-5576 52-0849320 ---------------------------- ------------ ------------------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 12051 Indian Creek Court, Beltsville, Maryland 20705 ---------------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code 301-419-3900 Not Applicable -------------------------------------------------------------- (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ SECTION 2 - FINANCIAL INFORMATION. - ---------------------------------- Item 2.02. Results of Operations and Financial Condition. ---------------------------------------------- On March 30, 2007, the Registrant issued a press release regarding its financial results for the year ended December 31, 2006. A copy of the press release is attached hereto as Exhibit 99.1. The information provided in this Current Report on Form 8-K is being provided pursuant to Item 2.02 of Form 8-K. The information in this report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such a filing. SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS. - ---------------------------------------------- Item 9.01. Financial Statements and Exhibits. ---------------------------------- Exhibit 99.1 - Press Release dated March 30, 2007. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Spherix Incorporated --------------------------- (Registrant) BY: /s/ Richard C. Levin ----------------------- Richard C. Levin CEO and President DATE: March 30, 2007 EX-99.1 2 si9480ex991.txt EXHIBIT 99.1 Exhibit 99.1 For additional information, contact Investor Relations, (301) 419-7877 March 30, 2007 Email: info@spherix.com SPHERIX REPORTS RECORD 2006 FINANCIAL RESULTS BELTSVILLE, MD, Spherix Incorporated (NASDAQ/SPEX) reported record revenue of $24.8 million for the year ended December 31, 2006, up 8% over 2005. The strong increase between years was the result of continued growth from InfoSpherix's (the Company's wholly-own subsidiary) popular Government Campground Reservation Business. The reported revenue numbers are exclusive of an additional $6 million the Company received as part of its settlement with the U.S. Department of Agriculture (see Spherix news release dated October 26, 2006), which the Company recorded as "Other Income" and which contributed significantly to the $6.3 million improvement in net income (loss) between years. Year Ended December 31 -------------------------------- 2006 2005 -------------- -------------- Revenue $ 24,838,174 $ 23,045,657 Operating expense (27,317,993) (25,931,550) -------------- -------------- Loss from operations $ (2,479,819) $ (2,885,893) Other income $ 6,097,750 $ 37,145 Income tax expense $ (105,050) $ - -------------- -------------- Net income (loss) $ 3,512,881 $ (2,848,748) Net income (loss) per share $ 0.26 $ (0.24) Spherix President Richard C. Levin said, "I am pleased at the continued improvement in financial results. Even without the $6 million settlement, we improved net income by $360,000. This includes an increase in R&D costs of $595,000 in expenses primarily for our Phase 3 clinical trial for Naturlose as a stand-alone drug to treat diabetes, which is proceeding on schedule." ---------- Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on March 3, 1999. Under its motto, "A World of Solutions," Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in information technology, knowledge management, and biotechnology. Our Internet address is http://www.spherix.com. # # # # # # -----END PRIVACY-ENHANCED MESSAGE-----